Atomistry » Calcium » PDB 5lif-5m2o » 5m0d
Atomistry »
  Calcium »
    PDB 5lif-5m2o »
      5m0d »

Calcium in PDB 5m0d: Structure-Based Evolution of A Hybrid Steroid Series of Autotaxin Inhibitors

Enzymatic activity of Structure-Based Evolution of A Hybrid Steroid Series of Autotaxin Inhibitors

All present enzymatic activity of Structure-Based Evolution of A Hybrid Steroid Series of Autotaxin Inhibitors:
3.1.4.39;

Protein crystallography data

The structure of Structure-Based Evolution of A Hybrid Steroid Series of Autotaxin Inhibitors, PDB code: 5m0d was solved by W.-J.Keune, T.Heidebrecht, A.Perrakis, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å) 75.34 / 2.40
Space group P 1 21 1
Cell size a, b, c (Å), α, β, γ (°) 62.927, 88.012, 77.356, 90.00, 103.10, 90.00
R / Rfree (%) 22.5 / 27

Other elements in 5m0d:

The structure of Structure-Based Evolution of A Hybrid Steroid Series of Autotaxin Inhibitors also contains other interesting chemical elements:

Zinc (Zn) 2 atoms
Iodine (I) 9 atoms
Chlorine (Cl) 2 atoms
Sodium (Na) 1 atom

Calcium Binding Sites:

The binding sites of Calcium atom in the Structure-Based Evolution of A Hybrid Steroid Series of Autotaxin Inhibitors (pdb code 5m0d). This binding sites where shown within 5.0 Angstroms radius around Calcium atom.
In total only one binding site of Calcium was determined in the Structure-Based Evolution of A Hybrid Steroid Series of Autotaxin Inhibitors, PDB code: 5m0d:

Calcium binding site 1 out of 1 in 5m0d

Go back to Calcium Binding Sites List in 5m0d
Calcium binding site 1 out of 1 in the Structure-Based Evolution of A Hybrid Steroid Series of Autotaxin Inhibitors


Mono view


Stereo pair view

A full contact list of Calcium with other atoms in the Ca binding site number 1 of Structure-Based Evolution of A Hybrid Steroid Series of Autotaxin Inhibitors within 5.0Å range:
probe atom residue distance (Å) B Occ
A:Ca920

b:45.1
occ:1.00
 O A:LEU745 2.3 43.3 1.0
OD1 A:ASN741 2.4 42.5 1.0
OD1 A:ASP747 2.4 47.4 1.0
OD1 A:ASP739 2.5 40.4 1.0
OD1 A:ASP743 2.5 41.5 1.0
CG A:ASP743 3.3 41.7 1.0
CG A:ASN741 3.4 43.1 1.0
C A:LEU745 3.5 43.2 1.0
CG A:ASP747 3.6 48.0 1.0
CG A:ASP739 3.6 40.2 1.0
OD2 A:ASP743 3.6 42.4 1.0
N A:ASP747 3.7 47.2 1.0
ND2 A:ASN741 3.8 43.5 1.0
CA A:ASP739 3.9 41.6 1.0
C A:ARG746 4.0 46.4 1.0
CA A:ASP747 4.0 48.4 1.0
N A:LEU745 4.2 41.4 1.0
CB A:ASP739 4.2 40.8 1.0
CA A:LEU745 4.3 42.1 1.0
O A:ARG746 4.3 46.7 1.0
CB A:ASP747 4.4 48.6 1.0
N A:ASP743 4.4 41.0 1.0
OD2 A:ASP747 4.4 48.2 1.0
O A:PHE738 4.4 42.1 1.0
N A:ARG746 4.4 44.1 1.0
CB A:LEU745 4.5 42.3 1.0
C A:ASP739 4.5 42.0 1.0
OE2 A:GLU751 4.5 57.9 1.0
OD2 A:ASP739 4.5 39.7 1.0
CB A:ASP743 4.6 41.2 1.0
CA A:ARG746 4.7 45.4 1.0
N A:ASN741 4.7 43.3 1.0
CB A:ASN741 4.7 43.6 1.0
N A:TYR742 4.7 42.0 1.0
N A:TYR740 4.8 43.0 1.0
CA A:ASP743 4.9 40.7 1.0
C A:ASN741 4.9 42.4 1.0
N A:GLY744 5.0 40.3 1.0

Reference:

W.J.Keune, F.Potjewyd, T.Heidebrecht, F.Salgado-Polo, S.J.Macdonald, L.Chelvarajan, A.Abdel Latif, S.Soman, A.J.Morris, A.J.Watson, C.Jamieson, A.Perrakis. Rational Design of Autotaxin Inhibitors By Structural Evolution of Endogenous Modulators. J. Med. Chem. V. 60 2006 2017.
ISSN: ISSN 1520-4804
PubMed: 28165241
DOI: 10.1021/ACS.JMEDCHEM.6B01743
Page generated: Wed Jul 9 08:02:53 2025

Last articles

Co in 1RQC
Co in 1RR2
Co in 1RQY
Co in 1RQH
Co in 1RQE
Co in 1RMQ
Co in 1RQB
Co in 1RL4
Co in 1REQ
Co in 1R8K
© Copyright 2008-2020 by atomistry.com
Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy